Peer Review History
| Original SubmissionJanuary 6, 2021 |
|---|
|
PONE-D-21-00523 Low educational level increases functional disability risk subsequent to heart failure in Japan: on behalf of the Iwate KENCO study group PLOS ONE Dear Dr. Takahashi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 02 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Antonio Palazón-Bru, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the Methods please provide a justification for the stratification of educational level according to the years of education. 3. We note that Figure 1 in your submission contains map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (a) present written permission from the copyright holder to publish this figure specifically under the CC BY 4.0 license, or (b) remove the figure from your submission: a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish this figure under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Please summarize concisely the principal implications of the finding. Explain how the findings may be important for policy, practice, or research…. Please provide recommendations for further research. Please explain how the results and conclusions of this study are important. Reviewer #2: Cohort study in which researchers identify patients who start out with heart failure and follow them for 11 years with the aim of identifying risk factors for the development of disability. Disability in patients with HF is common. The study is interesting because it is a prospective study in community-dwelling older adults aged 65 or older. The study analyzed two groups of patients with HF, one of them without disability (no LTCI) and the other one with disability (LTCI). Taking into account the objective of the study, it is not understood why the group of non-LTCI patients is analyzed. Comparison of the non-LTCI after HF group with the non-LTCI non-HF group identifies hypertension as a risk factor. In this case, it would be a risk factor for developing HF, fact already known. In the study, the functional disability is determined by the LTCI certification. This certification is done considering two dimensions: A) physical and psychological status and B) use of medical procedures. Its objective is to recognize the right to social and health benefits. Considering that, from the clinical point of view, it is not the usual way of assessing functional capacity, in the methods section, to facilitate the reader's understanding, it should be explained in a summarized way how the functional capacity of these patients is assessed. In the LTCI group, the proportion of patients with a lower educational level in the cases is double that in the controls. In these patients, the severity of heart failure is also probably higher than in highly educated patients. To control this possible bias, the model should have been adjusted with some variable indicative of heart failure severity (LVEF or NYHA). The LTCI system has been developed in Japan in order to assess care-needs in persons aged 65 and older. In order to understand the external validity of the study results, it is necessary that in the discussion section the results should be assessed in comparison with other scales to measure disability, generic or specific for patients with HF, such as the MLHFQ. The paragraph on page 5, lines 100-103, is repeated on page 7 lines 128-130. References must include studies that have identified risk factors for the development of disability in patients with heart failure. Reviewer #3: Summary of the Research and Overall Impression This paper uses a novel dataset to examine the pre-morbid risk factors that contribute to future disability (defined by enrollment in long-term care insurance, or LTCI) after heart failure (HF) in community-dwelling older adults in Japan. The goal is to contribute to earlier detection of high-risk patients and thereby facilitate more timely interventions. From a group of nearly 8,000 patients, the authors identified 96 who developed heart failure over the study period, and split these into two case groups, one of which required LTCI after HF, and the other which did not. Both groups were matched 3-to-one to same age/sex controls who had neither HF nor LTCI during the study period, and cases were compared to controls in both groups. The main results are that hypertension is associated with HF without LTCI, and lower education levels are associated with HF with LTCI. The topic is an important one given the aging population in Japan, the increasing prevalence of heart failure and the caregiving and quality-of-life costs associated with functional disability. However, the paper does not sufficiently explain the study sample or provide enough information about how to interpret these results with confidence. Specific Areas for Improvement Major Issues • More discussion of the case-control study design and how this affects how we interpret the results is needed to understand the study’s implications. For example, the case-control study design for the HF-Non LTCI subgroup needs more explanation. The control group has neither HF nor LTCI, while the case group has both; the comparison between them thus speaks to which pre-morbid conditions contribute to the compound outcome of a diagnosis of HF followed by no functional disability. One might suppose that the Table 2 result that hypertension is positively associated with the compound outcome (HF without LTCI) is picking up the association between hypertension and HF. But if this is so, then the same association should be seen in the (HF *with* LTCI) analysis. What does it mean that no such association appears in this second group? How should one interpret these two results together—that hypertension is protective against functional disability among patients with HF? More discussion about how to interpret this and other results in the paper is needed. • More detail is needed on the timing of the study and data collection for the reader to follow what has been done. The authors describe the study sample selection process beginning with 7,738 subjects age 65+, and refers to an earlier paper (Ohsawa et al. 2009) for details of the Iwate-KENCO study population. Ohsawa et al. state that the study began in 2002, but it appears that there were many more study participants age 65+ in 2002 (Table 1 in Ohsawa indicates more than 17,000 participants over age 60). To get to the 7,738 starting subjects for the current study, it seems many participants have been excluded from the original study, but there is insufficient detail to understand why that is. • The prior point is important because, after all sample selection steps, the current study ends up with fewer than 100 subjects (out of 7,738) who develop heart failure over the 11-year study period; this subgroup is further divided into 52 who did not require long-term care insurance and 44 who did. Some discussion of whether these sample sizes are large enough to detect the kinds of relationships we are looking for is needed. Are the authors confident that the relatively few statistically significant results found are not an artifact of too-small sample sizes? • In the Limitations section, the final limitation mentioned is that patients were required to travel to survey venues to participate in the study. This seems especially troubling as it likely limits the degree of disability among the study population, and makes it even more important to describe the study requirements more fully: what exactly was required of patients to participate in the study (frequency of contact, travel requirements such as distance and mode of transport, whether there were supplementary phone or at-home visits etc.)? Without understanding these items, it is difficult to judge how big an impact this limitation might have had. Minor Issues • The current study also says that subjects were followed for 11 years, but does not describe when the monitoring began and ended, nor how frequently patients were surveyed. • Line 145 suggests that anthropometric measurements were taken repeatedly. If there were multiple regular (say annual) assessments, how were they aggregated over the 11 years of the study? Miscellaneous Remarks • Functional disability was coded as a binary variable—either subjects were enrolled in the LTCI program or not. But apparently the LTCI certification system codes seven different levels of disability. Did the authors consider exploring a “dose effect” – that is, do patients with lower educational levels (or who drink more or smoke more) have higher levels of disability? I wonder if this might sharpen the results. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Low educational level increases functional disability risk subsequent to heart failure in Japan: on behalf of the Iwate KENCO study group PONE-D-21-00523R1 Dear Dr. Takahashi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Antonio Palazón-Bru, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-21-00523R1 Low educational level increases functional disability risk subsequent to heart failure in Japan: on behalf of the Iwate KENCO study group Dear Dr. Takahashi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Antonio Palazón-Bru Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .